Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,015.00    -10.00 (-0.17%)
Bid:
6,005.00
Ask:
6,010.00
Spread: 5.00 (0.083%)
Market Cap: £5.14b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Update on LTIP Performance Condition Ranges

4 Sep 2020 16:10

RNS Number : 1249Y
DCC PLC
04 September 2020
 

 

4 September 2020

 

Update on LTIP Performance Condition Ranges

 

As noted in the Annual Report and Accounts for the year ended 31 March 2020, the Remuneration Committee of DCC plc took a decision in May 2020, taking account of the impact of Covid-19, to defer until later in the first half of the year any decision on the threshold and maximum ranges for the Return on Capital Employed ('ROCE') and Earnings per Share ('EPS') performance conditions which would apply to awards made under the Company's Long Term Incentive Plan in the year ending 31 March 2021.

 

DCC plc announces that the Remuneration Committee has now agreed to set the threshold and maximum ranges for ROCE and EPS.

 

For the purposes of the ROCE performance condition, which accounts for up to 40% of an award, the Remuneration Committee has set a ROCE range for threshold and maximum vesting of 13% to 17%.

 

For the purposes of the EPS performance condition, which accounts for up to 40% of an award, the Remuneration Committee has set an EPS range for threshold and maximum vesting of UK RPI plus 3% per annum to UK RPI plus 7% per annum compound.

 

Both the ROCE range and the EPS range will be kept under review and adjusted if necessary in light of acquisition and other development activity in the year ending 31 March 2021.

 

As previously disclosed in the Annual Report and Accounts, the Total Shareholder Return ('TSR') performance condition, which accounts for up to 20% of an award, is based on TSR performance over a three-year period compared with the FTSE 100. Threshold vesting performance will be TSR equal to the median of the constituents of the index and maximum vesting will be TSR at or above the upper quartile.

 

For each of the ROCE, EPS and TSR performance conditions, threshold vesting will be 25% of maximum, with vesting determined on a straight-line basis between 25% and 100% for performance between threshold and maximum.

 

 

For reference:

Gerard Whyte

Company Secretary

 

Tel: +353 1 2799 400

Email: companysecretary@dcc.ie

Web: www.dcc.ie

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Technology and Healthcare. DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2020, DCC generated revenue of £14.8 billion and operating profit of £494 million.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRLIMATMTMMBLM
Date   Source Headline
14th Jul 20202:28 pmRNSHolding in Company TR-1
8th Jul 202011:38 amRNSHolding in Company TR-1
24th Jun 20209:39 amRNSHolding in Company TR-1
18th Jun 202012:25 pmRNS2020 Annual Report, Notice of AGM and Proxy Form
3rd Jun 202010:10 amRNSHolding in Company TR-1
29th May 202011:27 amRNSTotal Voting Rights
28th May 20206:21 pmRNSDirector/PDMR Shareholding
28th May 20201:02 pmRNSHolding in Company TR-1
19th May 20205:04 pmRNSBoard Changes
19th May 20207:00 amRNSResults for the year ended 31 March 2020
14th May 20203:30 pmRNSHolding in Company TR-1
27th Apr 20206:02 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20204:24 pmRNSDirector Declaration
9th Apr 20204:21 pmRNSHolding in Company TR-1
3rd Apr 20204:01 pmRNSHolding in Company TR-1
25th Mar 20203:22 pmRNSHolding in Company TR-1
25th Mar 20207:00 amRNSDCC Healthcare announces acquisition of Amerilab
19th Mar 20204:10 pmRNSHolding in Company TR-1
19th Mar 20209:46 amRNSHolding in Company TR-1
18th Mar 202012:14 pmRNSHolding in Company TR-1
6th Mar 20204:08 pmRNSHolding in Company TR-1
28th Feb 202010:54 amRNSTotal Voting Rights
24th Feb 20208:38 amRNSBoard Change
24th Feb 20208:34 amRNSChief Financial Officer Succession
12th Feb 20209:10 amRNSHolding in Company TR-1
4th Feb 20207:00 amRNSInterim Management Statement
17th Jan 20209:23 amRNSHolding in Company TR-1
3rd Jan 202010:03 amRNSHolding in Company - TR1
23rd Dec 201912:44 pmRNSHolding in Company TR-1
5th Dec 20195:44 pmRNSHolding in Company - TR1
29th Nov 20191:39 pmRNSTotal Voting Rights
27th Nov 20199:18 amRNSDirector Declaration
18th Nov 20196:14 pmRNSDirector/PDMR Shareholding
12th Nov 20197:00 amRNSResults for the six months ended 30 September 2019
12th Nov 20197:00 amRNSDCC Healthcare acquires Ion Laboratories
7th Nov 201911:30 amRNSHolding in Company TR-1
23rd Oct 20192:25 pmRNSHolding in Company TR-1
21st Oct 20195:01 pmRNSHolding in Company TR-1
18th Oct 20194:46 pmRNSHolding in Company TR-1
17th Oct 20199:43 amRNSHolding in Company TR-1
25th Sep 20195:39 pmRNSHolding in Company TR-1
4th Sep 20199:57 amRNSHolding in Company TR-1
9th Aug 201910:42 amRNSHolding in Company TR-1
7th Aug 20199:23 amRNSHolding in Company TR-1
31st Jul 20192:58 pmRNSTotal Voting Rights
16th Jul 20196:14 pmRNSDirector/PDMR Shareholding
12th Jul 20193:06 pmRNSResult of AGM
12th Jul 20197:00 amRNSInterim Management Statement
5th Jul 20199:06 amRNSHolding in Company TR-1
19th Jun 20199:22 amRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.